OrganiGram Holdings Inc
Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Ediso… Read more
OrganiGram Holdings Inc (OGI) - Total Assets
Latest total assets as of December 2025: $530.24 Million USD
Based on the latest financial reports, OrganiGram Holdings Inc (OGI) holds total assets worth $530.24 Million USD as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
OrganiGram Holdings Inc - Total Assets Trend (2012–2025)
This chart illustrates how OrganiGram Holdings Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
OrganiGram Holdings Inc - Asset Composition Analysis
Current Asset Composition (September 2025)
OrganiGram Holdings Inc's total assets of $530.24 Million consist of 50.7% current assets and 49.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 5.0% |
| Accounts Receivable | $64.86 Million | 11.5% |
| Inventory | $123.95 Million | 22.1% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $34.83 Million | 6.2% |
| Goodwill | $37.71 Million | 6.7% |
Asset Composition Trend (2012–2025)
This chart illustrates how OrganiGram Holdings Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: OrganiGram Holdings Inc's current assets represent 50.7% of total assets in 2025, a decrease from 69.5% in 2012.
- Cash Position: Cash and equivalents constituted 5.0% of total assets in 2025, down from 63.9% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 12.0% of total assets, an increase from 0.0% in 2012.
- Asset Diversification: The largest asset category is inventory at 22.1% of total assets.
OrganiGram Holdings Inc Competitors by Total Assets
Key competitors of OrganiGram Holdings Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
OrganiGram Holdings Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - OrganiGram Holdings Inc generates 0.33x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - OrganiGram Holdings Inc is currently not profitable relative to its asset base.
OrganiGram Holdings Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.73 | 3.36 | 9.92 |
| Quick Ratio | 1.32 | 1.85 | 8.06 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $162.36 Million | $ 162.53 Million | $ 234.35 Million |
OrganiGram Holdings Inc - Advanced Valuation Insights
This section examines the relationship between OrganiGram Holdings Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.74 |
| Latest Market Cap to Assets Ratio | 0.24 |
| Asset Growth Rate (YoY) | 37.8% |
| Total Assets | $562.21 Million |
| Market Capitalization | $135.42 Million USD |
Valuation Analysis
Below Book Valuation: The market values OrganiGram Holdings Inc's assets below their book value (0.24 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: OrganiGram Holdings Inc's assets grew by 37.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for OrganiGram Holdings Inc (2012–2025)
The table below shows the annual total assets of OrganiGram Holdings Inc from 2012 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-09-30 | $562.21 Million | +37.84% |
| 2024-09-30 | $407.86 Million | +36.66% |
| 2023-09-30 | $298.45 Million | -48.28% |
| 2022-09-30 | $577.11 Million | +4.17% |
| 2021-09-30 | $554.02 Million | +32.66% |
| 2020-09-30 | $417.62 Million | -2.54% |
| 2019-09-30 | $428.52 Million | +41.63% |
| 2018-09-30 | $302.57 Million | +226.01% |
| 2017-09-30 | $92.81 Million | +72.29% |
| 2016-09-30 | $53.87 Million | +279.98% |
| 2015-09-30 | $14.18 Million | +10030.36% |
| 2014-09-30 | $139.94K | -58.45% |
| 2013-09-30 | $336.76K | -32.84% |
| 2012-09-30 | $501.44K | -- |